Continuous NSAID offers no benefit over on-demand in ankylosing spondylitis

More evidence is needed to confirm whether continuous NSAID can reduce joint damage in people with ankylosing spondylitis. INTRODUCTION Ankylosing spondylitis is a chronic inflammatory disease. It mainly involves the joints, but may be associated with other diseases, such as psoriasis (a skin disease), inflammatory bowel disease and uveitis (an inflammation in the eye). These […]

Read More…

Tofacitinib effective despite previous biologic therapy

Tofacitinib is effective in reducing the signs and symptoms of rheumatoid arthritis when used either before or after biologics. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but there is also a […]

Read More…

Do patients prefer nurse specialists to manage their DMARD treatment?

INTRODUCTION People taking disease-modifying antirheumatic drugs (DMARDs) for inflammatory arthritis are more likely to be satisfied with their care if they have follow-up appointments with a clinical nurse specialist, rather than with a doctor, a study shows. WHAT DO WE KNOW ALREADY? ‘Inflammatory arthritis’ is an umbrella term that covers several conditions, including rheumatoid arthritis, ankylosing spondylitis, […]

Read More…